Neuro-Hitech Pharmaceuticals, Inc. Begins Trading Under Symbol ''NHPI’'; Private Placement Of $4.35 Million Coincides With Reverse Merger

NEW YORK--(BUSINESS WIRE)--Feb. 2, 2006--Neuro-Hitech Pharmaceuticals, Inc., a drug development company engaged in the development and commercialization of Huperzine A (HupA) for a variety of degenerative neurological disorders, today announced its stock will begin trading under the symbol OTC BB: NHPI today, February 2, 2006.